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Edited by Pascale CossartAbstract Yersinia encodes a protein kinase, YpkA, which dis-
rupts the actin cytoskeleton. Using an approach termed chemical
genetics, we identiﬁed a 36-kDa substrate for YpkA in both J774
lysates and bovine brain cytosol. Mass spectrometry analysis
identiﬁed this substrate as FLJ20113, an open reading frame
that corresponds to otubain 1, a deubiquitinating enzyme impli-
cated in immune cell clonal anergy. We demonstrate that otubain
1 is phosphorylated by YpkA in vitro and interacts with YpkA
and actin in vivo. Identiﬁcation of otubain 1 as a YpkA substrate
suggests that regulation of immune cell anergy may be a survival
mechanism for Yersinia.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Pathogenic Yersinia cause a variety of diseases including the
bubonic plague. Yersinia utilize a Type III secretion system to
translocate eﬀector proteins into host cells [1]. These eﬀectors,
referred to as Yops (Yersinia outer membrane proteins), in-
clude YopH, YopJ, YopE, YopT, YopM, and YpkA (YopO).
The Yops function to disrupt mammalian signaling cascades,
resulting in disturbance of the host innate immune system
allowing for bacterial survival [1].
YpkA (Yersinia protein kinase A) has similarity to the mam-
malian serine/threonine kinases [2]. YpkA is essential for viru-
lence, as disruption of YpkA results in an avirulent strain of
Yersinia [2]. We demonstrated that YpkA is produced as anAbbreviations: Yop, Yersinia outer membrane protein; YpkA, Yersinia
protein kinase A; SDS/PAGE, sodium dodecyl sulfate/polyacrylamide
gel electrophoresis; OTU, ovarian tumor; NDK, nucleoside diphos-
phate kinase; MALDI-MS, matrix-assisted laser desorption ioniza-
tion-mass spectrometry; TOF, time of ﬂight; PSD, post source decay;
MBP, myelin basic protein; EST, expressed sequence tag
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cell where it disrupts the actin cytoskeleton [3]. The only sub-
strate for YpkA identiﬁed to date is actin [3], and we hypoth-
esize that YpkA phosphorylates additional substrates which
are involved in rearranging the actin cytoskeleton or inhibiting
phagocytosis, thus ensuring survival of Yersinia.
Here, we report the use of chemical genetics to identify sub-
strates for YpkA. This approach allows for the identiﬁcation
of novel protein kinase substrates by altering the kinase active
site to accept a chemically modiﬁed form of ATP [4]. This
method permits one to screen a crude extract for substrates
with little background phosphorylation, as the mutated kinase
is the only kinase capable of eﬃciently using the chemically
modiﬁed ATP [5]. Chemical genetics has been employed suc-
cessfully for various kinases including JNK and v-Src [5,6].
Using a mutant form of YpkA, which shows a pronounced
preference for c-32P N6-phenethyl ATP, we show selective
phosphorylation of actin and another protein with an apparent
size of 36-kDa by sodium dodecyl sulfate/polyacrylamide gel
electrophoresis (SDS/PAGE). Using mass spectrometry we
identiﬁed this protein as otubain 1, a member of the family
of ovarian tumor (OTU)-like cysteine proteases involved in
the ubiquitin pathway [7]. We demonstrate phosphorylation
of otubain 1 by YpkA in vitro and further demonstrate a con-
nection between otubain 1 and the actin cytoskeleton. These
data suggest a role for otubain 1 in the pathogenic eﬀects ini-
tiated by YpkA.2. Materials and methods
2.1. Constructs
YpkA constructs have been previously described [3]. Otubain 1 was
PCR ampliﬁed from human expressed sequence tag (EST) clone
5300681 (Research Genetics) and subcloned into both pGEX-6p-2
(Amersham Pharmacia) for bacterial expression and pCDNA3 (Invit-
rogen) with an N-terminal HA tag for mammalian expression.
2.2. Expression of recombinant proteins
YpkA was expressed and puriﬁed as previously described [3]. The
vector pGEX-6p-2-otubain 1 was transformed into Novablue DE3
E. coli-competent cells (Stratagene) for protein expression. Otubain 1
was expressed and puriﬁed in the same manner as YpkA [3]. His-
tagged nucleoside diphosphate kinase (NDK, a gift from Justin Ble-
throw and David Morgan, University of California, San Francisco)
was puriﬁed as previously described [5].blished by Elsevier B.V. All rights reserved.
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N6-benzyl ADP, N6-cyclopentyl ADP, and N6-phenethyl ADP were
radiolabeled with His-NDK resin as previously described [5].
2.4. Kinase assays
Recombinantly expressed YpkA (1.5 lg) and either J774 cell extract
(3 lg), bovine brain fractionated proteins, or puriﬁed actin were incu-
bated in an in vitro kinase assay as previously described [3].
2.5. Preparation of mammalian extracts
J774 macrophages were cultured in Dulbeccos modiﬁed Eagles
medium containing 10% fetal bovine serum, 2 mM glutamine, and
100 lg/ml penicillin/streptomycin (Invitrogen). Approximately 107
cells were washed once with phosphate buﬀered saline and resuspended
in homogenization buﬀer (10 mM Tris, pH 7.5/10% sucrose/2 lg/ml
aprotinin/2 lg/ml leupeptin/0.2 mM phenylmethylsulfonyl ﬂuoride).
Cells were homogenized with 30 passes in a Dounce homogenizer.
The cell lysate was centrifuged at 5000 · g for 20 min to collect unbro-
ken cells and nuclei. Bovine brain cytosolic proteins were isolated as
previously described [3].
2.6. Protein identiﬁcation by matrix-assisted laser desorption ionization-
mass spectrometry (MALDI-MS)
The p36 band was excised from a stained SDS/PAGE gel and
digested with trypsin (Promega). Following in gel trypsin digestion,
extracted tryptic peptides were analyzed by matrix-assisted laser
desorption ionization/time of ﬂight (MALDI-TOF) mass spectrometry
on a Voyager-DE Pro time of ﬂight instrument (Applied Biosystems)
in linear positive mode to generate a peptide mass map. The peptide
mass values were used to search a non-redundant database (NCBInr)
using the software tool MS-Fit. MALDI-post source decay (PSD) was
performed on selected parent ions in reﬂectron mode for sequence
determination. PSD spectra were acquired in 8–10 segments with mir-
ror ratios ranging from 1.0 to 0.25, and stitched together using the
Data Explorer software.
2.7. Cell culture and western blot analysis
HEK293 cells were transfected using the FuGENE 6 transfection kit
(Roche Molecular Biochemicals) and lysed as described previously [3].
N-terminally FLAG epitope-tagged K269A-YpkA was immunopre-
cipitated using anti-FLAG M2 Sepharose resin (Sigma). Actin was
aﬃnity puriﬁed using DNase I-Sepharose aﬃnity resin (Worthington).
Aﬃnity puriﬁed samples were separated by SDS/PAGE, transferred to
nitrocellulose membranes and probed with the appropriate primary
and secondary antibodies followed by chemiluminescence detection.Fig. 1. Mutation of methionine 211 in YpkA alters its ATP speciﬁcity.
(A) Alignment of subdomain V of YpkA with other serine/threonine
and tyrosine kinases. (B) Recombinant wild-type, M211G, or M211A
YpkA (1.5 lg) was incubated with actin (1 lg), MBP (1 lg), and either
radiolabeled (c-32P) ATP or radiolabeled (c-32P) N6 ATP analogs
shown.3. Results and discussion
3.1. Modiﬁcation of YpkA for chemical genetics
Serine/threonine and tyrosine kinases contain a conserved
hydrophobic amino acid in subdomain V termed the ‘‘gate-
keeper residue’’ that is positioned adjacent to the N6 position
of the adenine ring in the ATP binding pocket [4]. Substitution
of this residue with small amino acids enables the mutated ki-
nase to accept chemically modiﬁed ATP analogs that contain a
bulky moiety at the N6 position [6]. These chemically modiﬁed
ATP analogs cannot be utilized by wild type kinases due to the
conservation of bulky side chain of the gatekeeper residue that
sterically clash with the substituent added to the N6 position in
the ATP analogs. This methodology, termed chemical genetics,
allows for the identiﬁcation of substrates for a kinase of inter-
est as one can use a mutant kinase with radiolabeled N6-mod-
iﬁed ATP in a crude extract with little background
phosphorylation compared to similar experiments when a wild
type kinase and radiolabeled ATP are used [4].
Alignment of subdomain V of YpkA with those of other ki-
nases revealed that methionine 211 is likely to be the conservedgatekeeper residue in YpkA (Fig. 1A). In order to determine
whether methionine 211 is the gatekeeper residue of YpkA,
we mutated methionine 211 to either glycine (M211G) or ala-
nine (M211A) and tested mutant YpkA kinase activity in the
presence of actin and the artiﬁcial substrate myelin basic pro-
tein (MBP) using either radiolabeled ATP or radiolabeled N6-
modiﬁed ATPs. Mutation of methionine 211 to glycine in
YpkA expands the ATP speciﬁcity of YpkA from ATP to
N6-modiﬁed ATP (Fig. 1B). Wild type YpkA utilizes the N6-
modiﬁed ATPs much less eﬃciently than it utilizes ATP as
determined by poor MBP phosphorylation and a lack of auto-
phosphorylation in the presence of N6-modiﬁed ATPs
(Fig. 1B). Mutation of methionine 211 to alanine in YpkA al-
ters the ATP speciﬁcity to a lesser degree, presumably due to
the presence of the side chain methyl group on alanine within
the ATP binding pocket (Fig. 1B). These data demonstrate
that methionine 211 is the conserved gatekeeper hydrophobic
residue within subdomain V of YpkA.
3.2. Identiﬁcation of a novel 36-kDa substrate for YpkA
YpkAM211G was added to a J774 macrophage extract with
radiolabeled (c-32P) N6-phenethyl ATP, as YpkA M211G
showed slightly increased phosphorylation of MBP with this
analog. Control experiments show that wild type YpkA phos-
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tle background phosphorylation was seen in extracts incubated
with radiolabeled (c-32P) N6-phenethyl ATP in the absence or
presence of YpkA M211G (Fig. 2A), demonstrating the spec-
iﬁcity of the chemical genetics approach. YpkA M211G specif-
ically phosphorylated itself and actin as expected, as well as a
36-kDa protein (p36) present in the J774 extract (Fig. 2A).
Interestingly, during the puriﬁcation of actin as an activator
of YpkA [3], we routinely observed a 36-kDa protein within
bovine brain extracts that co-eluted with actin from a gel ﬁltra-
tion column that was phosphorylated in the presence of wild
type YpkA (data not shown). To further analyze the nature
of p36 we fractionated bovine brain extract and followed its
phosphorylation by YpkA using the chemical genetics ap-
proach. Fractions containing actin and p36 were incubated
with M211G YpkA and radiolabeled (c-32P) N6-phenethyl
ATP. As shown in Fig. 2B, YpkA M211G phosphorylated a
36-kDa protein within fractionated bovine brain extracts.
Thus, the chemical genetics approach conﬁrmed a novel 36-Fig. 2. YpkA phosphorylates a 36-kDa protein in macrophages and
brain extract. (A) J774A macrophage lysates (5 lg protein) were
incubated with radiolabeled N6 phenethyl (PE) ATP and M211G
YpkA. (B) Bovine brain cytosol fractions from a gel ﬁltration column
were incubated with radiolabeled N6 phenethyl ATP and M211G
YpkA. Fractions 35–39 were previously found to contain both actin
and p36 (data not shown).kDa protein substrate for YpkA present in both J774 and bo-
vine brain extracts.3.3. Identiﬁcation of p36 as human open reading frame
FLJ20113/Otubain 1
Bovine brain extract fractions containing p36 were subjected
to SDS/PAGE and the band corresponding to p36 was excised
and subjected to in-gel trypsin digestion. The pool of tryptic
peptides was analyzed by MALDI-TOF mass spectrometry
(Fig. 3). The mass ﬁngerprint of p36 best matched a human
open reading frame FLJ20113 (Fig. 3A). MALDI-PSD
(PSD), which analyzes product ion fragments originating
through metastable decomposition of the precursor ion, was
performed on two p36 peptides, and conﬁrmed the FLJ20113
identiﬁcation (Fig. 3B and C).
As the analyzed sample was from bovine brain and the iden-
tiﬁed protein was a human ORF, the human FLJ20113 se-
quence was used to search the EST database for related
bovine sequences. Sequence alignment searches revealed that
FLJ20113 bears 99% identity to other predicted amino acid se-
quences from higher eukaryotes, including bovine. Impor-
tantly, the peptides identiﬁed by MALDI-TOF and PSD
sequencing are identical between FLJ20113 and the bovine
orthologue. FLJ20113 shares signiﬁcant similarity to the
OTU cysteine proteases [8]. Borodovsky et al. isolated
FLJ20113 (termed HSPC263 in the study) as a novel deubiqui-
tinating enzyme [9]. Recently, the protein encoded by
FLJ20113 was named otubain 1 (OTU-domain ubiquitin alde-
hyde-binding protein) as a member of a family of cysteine pro-
teases involved in ubiquitin signaling capable of cleaving tetra-
ubiquitin at the iso-peptide bond [7].3.4. Otubain 1 is a substrate for YpkA and interacts with the
actin cytoskeleton
To verify that YpkA can phosphorylate otubain 1, diﬀerent
amounts of otubain 1 were incubated with YpkA and actin.
YpkA is capable of phosphorylating otubain 1 in vitro only
when actin is present to activate YpkA (Fig. 4A). To test the
interaction between otubain 1 and YpkA, HEK293 cells were
co-transfected with HA-tagged variants of wild type or mutant
(D88A, C91S) otubain 1 and FLAG-epitope tagged YpkA
K269A, a kinase dead mutant [3]. YpkA was immunoprecipi-
tated using anti-FLAG M2 aﬃnity resin and anti-HA immu-
noblot analysis conﬁrmed that otubain 1 associates with
YpkA (Fig. 4B).
To examine whether otubain 1 interacts with the actin cyto-
skeleton, HEK293 cells were transfected with HA-tagged vari-
ants of otubain 1. Actin was aﬃnity puriﬁed using a DNase-I
aﬃnity resin, and co-precipitated otubain 1 was detected by
immunoblot analysis using an HA antiserum. Otubain 1 was
detected in the actin aﬃnity puriﬁcation, indicating that it
interacts with either actin or an actin-associated protein
(Fig. 4B). The strongest otubain/actin interaction observed
was between the actin cytoskeleton and the C91S mutant of
otubain 1. The C91S mutant may act as a substrate-trapping
mutant as has been suggested for other mutated cysteine pro-
teases including caspase-1 [10], suggesting that a substrate for
otubain is either actin or an actin-associated protein.
We have identiﬁed otubain 1 as a novel substrate for the
Yersinia kinase YpkA using chemical genetics coupled to
mass spectrometry. YpkA phosphorylation of otubain 1
Fig. 3. Identiﬁcation of p36 as FLJ20113 using MALDI-TOF and MALDI-PSD mass spectrometry. (A) MALDI-TOF mass ﬁngerprint of the
tryptic pool of p36 peptides. The two peptides analyzed by MALDI-PSD are marked with an asterisk. (B) MALDI-PSD spectrum for m/z 1238. (C)
MALDI-PSD spectrum for m/z 1724. The observed C-terminal (y) and N-terminal (b) fragment ions are indicated on the spectrum and peptide
sequence.
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lytic activity, localization, or protein stability. Interestingly,
otubain 1 is phosphorylated in HeLa cells by an unknown
serine/threonine kinase [11], suggesting otubain 1 is regulated
by phosphorylation in vivo. As otubain 1 has been shown to
interact with the E3 ligase GRAIL, leading to GRAIL deg-
radation and repression of T-cell anergy [12], it is tempting
to speculate that otubain 1 phosphorylation by YpkA maydisrupt the GRAIL-otubain 1 complex in macrophages, sta-
bilize GRAIL, and induce macrophage anergy. This disrup-
tion of GRAIL signaling would suppress phagocytosis and
increase Yersinia survival. Current eﬀorts directed towards
examining all possible consequences of otubain 1 phosphor-
ylation by YpkA should aid in understanding the molecular
details of how this mechanism is advantageous for Yersinia
pathogenesis.
Fig. 4. Otubain 1 is a substrate for YpkA and interacts with YpkA and the actin cytoskeleton. (A) Recombinant otubain 1 was added in increasing
concentrations (250 ng, 625 ng, 1.25 lg and 2.5 lg) with recombinant YpkA (1.5 lg) and actin (1 lg) in in vitro kinase assays as described [3]. (B)
HEK293 cells were transfected with the otubain 1 constructs indicated alone (top and middle panels, 5 lg) or co-transfected with FLAG-epitope-
tagged YpkA K269A (bottom panel, 2.5 lg each). YpkA was immunoprecipitated using anti-FLAG M2 aﬃnity resin (bottom panel). Actin was
aﬃnity puriﬁed using a DNase-I sepharose aﬃnity resin (top panel). Otubain 1 was immunoprecipitated using an anti-HA antibody followed by
incubation with Protein A-agarose (middle panel). Immunoprecipitated otubain 1 was detected using an anti-HA antibody.
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